Breaking barriers in crosslinking mass spectrometry with enhanced throughput and sensitivity using Orbitrap Astral www.nature.com/artic...
---
#proteomics #prot-paper
Breaking barriers in crosslinking mass spectrometry with enhanced throughput and sensitivity using Orbitrap Astral www.nature.com/artic...
---
#proteomics #prot-paper
RosettaFold 3 is here! π§¬π
AtomWorks (the foundational data pipeline powering it) is perhaps the really most exciting part of this release!
Congratulations @simonmathis.bsky.social and team!!! β€οΈ
bioRxiv preprint: www.biorxiv.org/content/10.1...
Check out Structural HostβVirus Interactome Profiling (SHVIP) in intact cells infected with Herpes Simplex Virus type 1 (HSV-1)! Now published!
π www.nature.com/articles/s41...
#LoveVirology #TeamMassSpec
Happy to have been able to contribute to Larsβ work!
19.06.2025 10:02 β π 2 π 1 π¬ 0 π 0
Foldseek-Multimer is a strategy for complex-to-complex protein structure alignment to quickly perform large-scale structural comparisons between complexes. @martinsteinegger.bsky.social
www.nature.com/articles/s41...
It was nice to be able to contribute to Borisβ study on improving error control in XL-MS!
#Proteomics #TeamMassSpec
www.embopress.org/doi/full/10....
We have released version 2 of AlphaPulldown - a general pipeline for high-throughput structural modeling!
Software: github.com/KosinskiLab/...
Preprint: biorxiv.org/content/10.1...
Scout, our high speed search engine, is finally published. Additionally, we developed a standard, ground truth dataset for cross-linking Mass Spectrometry which guided the development of Scout.
#XLMS #Massspec #Proteomics
www.nature.com/articles/s41...
PROTEOME-SCALE RECOMBINANT STANDARDS AND A ROBUST HIGH-SPEED SEARCH ENGINE TO ADVANCE CROSS-LINKING MS-BASED INTERACTOMICS https://www.biorxiv.org/content/10.1101/2023.11.30.569448v1
02.12.2023 23:51 β π 2 π 1 π¬ 1 π 0
Cross-linking goes bioorthogonal!
In our new preprint, we achieve higher coverage virus-host crosslinks than traditional interaction proteomics approaches by specifically labeling viral proteins, and can characterize new interaction sites in disordered regions via AF-multimer.